Elinzanetant is the first neurokinin-targeted therapy to demonstrate efficacy in reducing vasomotor symptoms (VMS)” — ...

Merck's Enflonsia vaccine for respiratory syncytial virus won approval from the Centers for Disease Control and Prevention's ...

Hydroxychloroquine is tied to reduced preeclampsia risk but not preterm birth risk in pregnant patients with lupus in a ...

When Pascal Soriot flew in to speak at the Boao Forum in China this year, many expected him to keep a low profile. With ...

When Pascal Soriot flew in to speak at the Boao Forum in China this year, many expected him to keep a low profile. With ...

Bengaluru: Global biopharmaceutical company AstraZeneca is investing Rs166 crore to expand its Bengaluru operations, creating ...

Biopharmaceutical firm AstraZeneca on Thursday said it has expanded its global hub in Bengaluru with an investment of Rs166 ...

A potential $4 billion licensing deal with Vor Bio triggered a slide in RemeGen's stock price. Otsuka obtained a BCMAXCD3 ...

In this week’s edition of The Prototype, we look at cancer-killing fungi, robots that perform surgery on your eyeballs, ...

AstraZeneca has launched a Phase I clinical study titled An Open-label, Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 Followi ...

AI has been a buzzword in the pharmaceutical industry for almost a decade, with countless headlines promising to ...

Targeted therapies and immunotherapy can provide benefits when added to chemotherapy or may eliminate the need for ...